Panel Discussion: Scaling Up & Meeting Oligonucleotide Demand
Time: 11:30 am
day: Day Two
Details:
• Moving into non-rare disease areas and producing oligonucleotides at scale for larger populations
• Evaluating technologies and the advantages and limitations of scale
• Analytical readiness for process change and late phase: strategic, regulatory, and technical perspectives
